The Recall Desk
SevereFDA (Drugs)·D-0754-2026·Announced 2026-08-19

Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

Apollo Care, LLC is recalling 250 vials of Semaglutide 5mg due to the presence of nylon and silk-type particulate matter.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury or property damage reports.

Plain-English summary

Apollo Care, LLC is voluntarily recalling 250 vials of Semaglutide 5mg (1mg/mL) with Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vials. The product is identified by NDC 71170-712-03, Lot AC-017272, and an expiration date of 12/12/2026.

The recall was initiated because the product contains particulate matter identified as nylon/polyamide and silk/proteinaceous-type material. The affected units were distributed nationwide within the United States.

Consumers and healthcare providers should stop using the recalled product and contact Apollo Care, LLC or their healthcare provider for further instructions.

The recalled product

Product
SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
Manufacturer
Apollo Care, LLC
Category
Drug — Injectable Medication
Hazard
Affected units
250

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot: AC-017272
  • Exp. 12/12/2026.

Distribution

Distributed nationwide across the United States.

Related recalls

Same manufacturer · Apollo Care, LLC

See all →

Same hazard · particulate matter

See all →